degraders | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

424 results for “degraders”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

60 participants · First posted Aug 1, 2025

FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma

84 participants · First posted Jan 16, 2024

Gold Laser Vs. Micro-Debriders for Functional Endoscopic Sinus Surgery

First posted Sep 14, 2016

Active, not recruiting

Intervention for Low-performing First Graders in Mathematics

10 participants · First posted Feb 2, 2023

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

361 participants · First posted Jun 19, 2025

Improving Mental Health and School Performance in Urban Eighth Graders

615 participants · First posted Apr 8, 2019

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

8 participants · First posted Feb 12, 2026

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

146 participants · First posted Mar 24, 2022

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

171 participants · First posted Sep 29, 2025

Daily Living Skills Intervention for 9th and 10th Graders With Autism Spectrum Disorders

58 participants · First posted Jun 13, 2019

Page 1 of 2